|IL-27 and IL-21 are associated with T cell IL-10 responses in human visceral leishmaniasis|
NA Ansari, R Kumar, S Gautam, S NylÚn, OP Singh, S Sundar, D Sacks
The Journal of Immunology 186 (7), 3977-3985, 2011
|Asymptomatic Leishmania Infection: A New Challenge for Leishmania Control|
OP Singh, E Hasker, D Sacks, M Boelaert, S Sundar
Clinical Infectious Diseases 58 (10), 1424-1429, 2014
|Current challenges in treatment options for visceral leishmaniasis in India: a public health perspective|
OP Singh, B Singh, J Chakravarty, S Sundar
Infectious diseases of poverty 5 (1), 1-15, 2016
|Reassessment of immune correlates in human visceral leishmaniasis as defined by cytokine release in whole blood|
OP Singh, K Gidwani, R Kumar, S NylÚn, SL Jones, M Boelaert, D Sacks, ...
Clinical and Vaccine Immunology 19 (6), 961-966, 2012
|Immunotherapy and targeted therapies in treatment of visceral leishmaniasis: current status and future prospects|
OP Singh, S Sundar
Frontiers in immunology 5, 296, 2014
|Elimination of visceral leishmaniasis on the Indian subcontinent|
OP Singh, E Hasker, M Boelaert, S Sundar
The Lancet infectious diseases 16 (12), e304-e309, 2016
|Strong association between serological status and probability of progression to clinical visceral leishmaniasis in prospective cohort studies in India and Nepal|
E Hasker, P Malaviya, K Gidwani, A Picado, B Ostyn, S Kansal, RP Singh, ...
PLoS neglected tropical diseases 8 (1), e2657, 2014
|Developments in diagnosis of visceral leishmaniasis in the elimination era|
OP Singh, S Sundar
Journal of parasitology research 2015, 2015
|Cytokine responses to novel antigens in an Indian population living in an area endemic for visceral leishmaniasis|
OP Singh, CB Stober, AK Singh, JM Blackwell, S Sundar
PLoS Negl Trop Dis 6 (10), e1874, 2012
|Leishmania specific CD4 T cells release IFNγ that limits parasite replication in patients with visceral leishmaniasis|
R Kumar, N Singh, S Gautam, OP Singh, K Gidwani, M Rai, D Sacks, ...
PLoS Negl Trop Dis 8 (10), e3198, 2014
|Strategies to overcome antileishmanial drugs unresponsiveness|
S Sundar, A Singh, OP Singh
Journal of tropical medicine 2014, 2014
|IgG1 as a potential biomarker of post-chemotherapeutic relapse in visceral leishmaniasis, and adaptation to a rapid diagnostic test|
T Bhattacharyya, A Ayandeh, AK Falconar, S Sundar, S El-Safi, ...
PLoS Negl Trop Dis 8 (10), e3273, 2014
|Significantly lower anti-Leishmania IgG responses in Sudanese versus Indian visceral leishmaniasis|
T Bhattacharyya, DE Bowes, S El-Safi, S Sundar, AK Falconar, OP Singh, ...
PLoS Negl Trop Dis 8 (2), e2675, 2014
|Molecular diagnosis of visceral leishmaniasis|
S Sundar, OP Singh
Molecular diagnosis & therapy 22 (4), 443-457, 2018
|Whole blood assay and visceral leishmaniasis: challenges and promises|
OP Singh, S Sundar
Immunobiology 219 (4), 323-328, 2014
|rK39 antigen for the diagnosis of visceral leishmaniasis by using human saliva|
M Vaish, OP Singh, J Chakravarty, S Sundar
The American journal of tropical medicine and hygiene 86 (4), 598-600, 2012
|Determinants for progression from asymptomatic infection to symptomatic visceral leishmaniasis: A cohort study|
J Chakravarty, E Hasker, S Kansal, OP Singh, P Malaviya, AK Singh, ...
PLoS neglected tropical diseases 13 (3), e0007216, 2019
|Detection of immunoglobulin G1 against rK39 improves monitoring of treatment outcomes in visceral Leishmaniasis|
G Mollett, BC Bremer Hinckel, T Bhattacharyya, T Marlais, OP Singh, ...
Clinical Infectious Diseases 69 (7), 1130-1135, 2019
|Visceral leishmaniasis IgG1 rapid monitoring of cure vs. relapse, and potential for diagnosis of post kala-azar dermal leishmaniasis|
T Marlais, T Bhattacharyya, OP Singh, P Mertens, Q Gilleman, ...
Frontiers in cellular and infection microbiology 8, 427, 2018
|Visceral leishmaniasis: spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India|
CA Bulstra, EA Le Rutte, P Malaviya, EC Hasker, LE Coffeng, A Picado, ...
PLoS neglected tropical diseases 12 (12), e0006888, 2018